Hypermarcas (HYPMY) Stock Price, News & Analysis

Company Overview

Hypermarcas S.A. is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products. Its pharmaceutical lineup includes analgesics, anti-inflammatories, vitamins and dermatological preparations, while its consumer goods segment encompasses shampoos, soaps, lotions and oral hygiene items under multiple local brands.

Primarily focused on the domestic Brazilian market, Hypermarcas has also extended its reach into other Latin American countries via export partnerships and regional distributors. Over the years, the company has grown through acquisitions of smaller domestic drugmakers and consolidation of well-known local brands. Detailed executive leadership information is not widely available in public sources.

Key Stats

• Today's Range: $4.41 to $4.80
• 50-Day Range: $4.01 to $5.02
• 52-Week Range: $2.64 to $5.30
• Volume: 8,233 shs
• Average Volume: 9,134 shs
• Market Capitalization: $2.91 billion
• P/E Ratio: 21.91
• Dividend Yield: 2.61%
• Price Target: N/A
• Consensus Rating: Strong Buy

HYPMY Stock Analysis - Frequently Asked Questions

How have HYPMY shares performed this year?

Hypermarcas' stock was trading at $3.06 at the beginning of 2025. Since then, HYPMY stock has increased by 50.3% and is now trading at $4.60.

How were Hypermarcas' earnings last quarter?

Hypermarcas (OTCMKTS:HYPMY) announced its quarterly earnings results on Wednesday, August, 6th. The company reported $0.12 EPS for the quarter. Hypermarcas had a net margin of 11.28% and a trailing twelve-month return on equity of 6.19%.

How do I buy shares of Hypermarcas?

Shares of HYPMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 8/06/2025
• Today: 9/19/2025
• Next Earnings (Estimated): 10/29/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:HYPMY
• CIK: 1486749
• Web: www.hyperapharma.com.br
• Phone: 55-11-3627-4206
• Fax: N/A
• Employees: 10,481
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $0.21
• Trailing P/E Ratio: 21.91
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $248.62 million
• Net Margins: 11.28%
• Pretax Margin: 2.82%
• Return on Equity: 6.19%
• Return on Assets: 2.98%

Debt

• Debt-to-Equity Ratio: 0.63
• Current Ratio: 1.26
• Quick Ratio: 0.80

Sales & Book Value

• Annual Sales: $1.38 billion
• Price / Sales: 2.11
• Cash Flow: $0.47 per share
• Price / Cash Flow: 9.82
• Book Value: $3.54 per share
• Price / Book: 1.30

Miscellaneous

• Outstanding Shares: 633,421,000
• Free Float: N/A
• Market Cap: $2.91 billion
• Optionable: Not Optionable
• Beta: 0.86